Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dino's Bar & Grill -- Ignore unavailable to you. Want to Upgrade?

To: Goose94 who wrote (4114)	1/23/2014 3:27:07 PM
From: Andrew~	Read Replies (1) \| Respond to of 202700

PHM-V Patient Home Monitoring (PHM) Announces Upcoming Earnings Call SAN FRANCISCO, CALIFORNIA--(Marketwired - Jan. 23, 2014) - Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company focused on rolling-up annuity-based healthcare service companies in the US and Canada, today announced that it will host an Internet audio webcast, of the investor conference call, to review the improved financial performance from both fiscal first quarter 2014 and its fiscal year end 2013 at 4:30 p.m. EST Wednesday, Jan. 29, 2014. At the close of regular trading on Tuesday, January 28, 2014, PHM will issue a press release disclosing financial results for the fiscal first quarter 2014 and the fiscal year ended September 30, 2013. The Internet webcast can be accessed via the investors section of the PHM corporate website, www.phmhometesting.com. Replays of the conference call will be available via the Internet in the investors section of the PHM corporate website. http://stockboard.com/news/view.php/patient-home-monitoring-phm-announces-upcoming-earnings-call

To: Goose94 who wrote (4114)	6/4/2014 9:15:56 AM
From: Goose94	Read Replies (2) \| Respond to of 202700

Patient Home Monitoring (PHM-V) June 4, '14 has closed the acquisition of Care Medical Partners LLC, a profitable Georgia-based company focused on providing home-based chronic pulmonology services. The acquisition is expected to have an immediate and substantial impact on earnings-per-share (EPS) and is expected to increase total run-rate revenues of PHM to over $27 million annually. Acquisition PHM Post-Acquisition is expected to generate: -- Over $27 million in annual run-rate revenue -- Over $5.75 million in annual run-rate EBITDA -- Significant new organic growth cross-selling opportunities designed to generate additional revenue and profit growth Care Medical generated over $13.1 million in revenue for the period between March 31, 2013 and March 31, 2014, with just over $2 million in Adjusted EBITDA(1) over the same period, based upon final unaudited due diligence. PHM paid $5,476,150 for the acquisition, which is equivalent to 2.72 times trailing 12-month unaudited Adjusted EBITDA(1), paid in cash, stock and acquisition of medical equipment leases. Under the terms of the Definitive Purchase Agreement, PHM will acquire 100% of the units of Care Medical for a total consideration of (1) US $144,243.60 in cash to the sellers and (2) 5,655,476 shares of PHM issued to the sellers, subject to TSX approval. The sellers agreed to take PHM shares at a share value of US$0.26 per share or equivalent of approximately CAD$0.28 per share. As part of the transaction, PHM will acquire $3.15 million in medical equipment placed with patients generating revenue through paying various leases and loans. PHM plans to secure additional debt financing in the near future with a focus to increase shareholder value for this and other medical equipment acquired to service patients. "There is an immediate and positive EPS impact with this acquisition," said Michael Dalsin, Chairman and CEO of PHM. "While the acquisition will only be reflected in PHM's financial statements for the last month of the current quarter, I expect there to be a significant impact on this quarter's financial results with the full force of revenue and profits being recorded in this year's fiscal fourth quarter." "Care Medical is a complimentary fit with our previous South Carolina acquisitions both in services offered and geographically," continued Mr. Dalsin. "With our latest acquisitions in Florida, South Carolina, and Georgia, we are solidifying PHM's regional presence in the southeastern United States while at the same time providing significant expansion opportunities for our California-based cardiology service business unit. While we were able to acquire this business at a favorable multiple, I expect our post integration multiple to be much lower. Andrew Folmer and the operational team plan to efficiently integrate the business into PHM and are focused on generating organic and cross-selling revenue immediately within the existing growing patient database." "Our M&A team is nearing the LOI stage with two additional acquisition targets and I expect to have the next deal lined up shortly," Mr. Dalsin concluded. "We have plenty of cash and a solid balance sheet combined with strong positive cash flow, which puts PHM in a position to close these subsequent transactions without additional equity financing."